⌘K
Loading ticker…
As of 2026-08-24, Scilex Holding Company Common Stock (SCLX) has a 3-month relative strength percentile of 34 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 37. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.8%, relative volume 0.96×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
SCLX is in a stage 4 downtrend, week 5. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -22.8% / -42.4%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
SCLX appears in 1 ETF as of May 2026: AVTM at 0.00% weight, $712 notional.
Held by 6 ETFs · $2M across latest filings · largest weight 0.03% (IWC).
Top 1 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| AVTM | 0.00% | $712 | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SCLX Jan avg: 11.14% median: -11.50% win: 25% σ: 58.77% n: 4 2022-11-14 → 2026-07-31 | SCLX Feb avg: 0.43% median: 3.00% win: 50% σ: 33.69% n: 4 2022-11-14 → 2026-07-31 | SCLX Mar avg: -12.19% median: -12.04% win: 25% σ: 15.44% n: 4 2022-11-14 → 2026-07-31 | SCLX Apr avg: -11.40% median: -28.60% win: 25% σ: 48.97% n: 4 2022-11-14 → 2026-07-31 | SCLX May avg: 0.35% median: -3.69% win: 50% σ: 21.02% n: 4 2022-11-14 → 2026-07-31 | SCLX Jun avg: 18.75% median: 4.33% win: 50% σ: 41.66% n: 4 2022-11-14 → 2026-07-31 | SCLX Jul avg: 23.47% median: -8.17% win: 25% σ: 69.92% n: 4 2022-11-14 → 2026-07-31 | SCLX Aug avg: -14.29% median: -27.67% win: 33% σ: 41.58% n: 3 2022-11-14 → 2026-07-31 (current) | SCLX Sep avg: -20.00% median: -19.60% win: 33% σ: 31.02% n: 3 2022-11-14 → 2026-07-31 | SCLX Oct avg: 7.09% median: 3.86% win: 67% σ: 25.02% n: 3 2022-11-14 → 2026-07-31 | SCLX Nov avg: -23.65% median: -33.07% win: 25% σ: 32.59% n: 4 2022-11-14 → 2026-07-31 | SCLX Dec avg: -5.50% median: -22.55% win: 25% σ: 47.43% n: 4 2022-11-14 → 2026-07-31 |